
A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants.
The Transform trial, a collaborative effort funded by Prostate Cancer UK and the National Institute for Health and Care Research (NIHR), could yield significant results and prompt changes to current screening practices within just two years.